Topical acyclovir treatment of herpes zoster in immunocompromised patients
Authors:
- Myron J. LevinMLMyron J. Levin
- John A. ZaiaJZJohn A. Zaia
- Brenda J. HersheyBHBrenda J. Hershey
- L. Gray DavisLDL. Gray Davis
- Gayle V. RobinsonGRGayle V. Robinson
- Anthony C. SegretiASAnthony C. Segreti
- 1 October 1985
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 13 (4) , 590-596
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir TherapyThe Journal of Infectious Diseases, 1984
- Acyclovir Halts Progression of Herpes Zoster in Immunocompromised PatientsNew England Journal of Medicine, 1983
- Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed PatientsNew England Journal of Medicine, 1982
- ACYCLOVIR THERAPY FOR ACUTE HERPES ZOSTERThe Lancet, 1982
- ACYCLOVIR IN HERPES ZOSTERThe Lancet, 1981
- ACYCLOVIR THERAPY FOR MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN IMMUNOCOMPROMISED PATIENTSThe Lancet, 1981
- VARICELLA-ZOSTER VIRUS INFECTION AFTER MARROW TRANSPLANTATION FOR APLASTIC ANEMIA OR LEUKEMIATransplantation, 1980
- Herpes Zoster-Varicella Infections in Immunosuppressed PatientsAnnals of Internal Medicine, 1978
- Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with CancerNew England Journal of Medicine, 1978
- Varicella-Zoster Infection in Patients with CancerAnnals of Internal Medicine, 1972